CIM
TECH icon

Calvert Investment Management’s Bio-Techne TECH Stock Holding History

Calvert Investment Management’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-9,148
Closed -$235K – 541
2016
Q4 		$235K Sell
9,148
-324
-3% -$8.51K 0.01% 737
2016
Q3 		$259K Buy
9,472
+716
+8% +$19.7K 0.01% 697
2016
Q2 		$247K Buy
+8,756
New +$225K 0.01% 672

Other funds holding TECH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
ACM
Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
MPI
Mairs & Power Inc St Paul, Minnesota $9.79B AUM 20.6% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Calvert Investment Management's TECH Position: Q1 2017 in Review

Calvert Investment Management sold out of Bio-Techne (TECH) in Q1 2017, closing a stake of 9,148 shares — an estimated $235K sold.

Calvert Investment Management first reported a position in TECH in Q2 2016 and held it in 3 quarters. The position peaked at $259K in Q3 2016. 271 funds tracked by Wall St. Rank hold TECH as of Q1 2017.

  • Calvert Investment Management reported no remaining Bio-Techne position as of Q1 2017 after selling out during the quarter.
  • Calvert Investment Management sold 9,148 Bio-Techne shares in Q1 2017, an estimated $235K.
  • Calvert Investment Management first reported a position in Bio-Techne in Q2 2016 and held it in 3 quarters.
  • Calvert Investment Management's Bio-Techne position peaked at $259K in Q3 2016.
  • 271 funds tracked by Wall St. Rank held Bio-Techne as of Q1 2017.

Based on Calvert Investment Management's 13F filing for Q1 2017.